Ignite Creation Date:
2024-10-26 @ 3:39 PM
Last Modification Date:
2024-10-26 @ 3:39 PM
Study NCT ID:
NCT06580743
Status:
RECRUITING
Last Update Posted:
None
First Post:
2024-08-16
Brief Title:
Efficacy Verification in Early Diagnosis and Management of Lymphedema Through Home Body Water Analyzer
Sponsor:
None
Organization:
None
Study Overview
Official Title:
Efficacy Verification in Early Diagnosis and Management of Lymphedema Through Home Body Water Analyzer
Status:
RECRUITING
Status Verified Date:
2024-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Breast cancer is the second most common cancer in women One in five women who have been treated for breast cancer develop lymphedema Lymphedema is a very common result of breast cancer and its treatment Lymphedema is the build-up of fluid in tissues which results in tissue swelling The lymph system is a network of lymph vessels tissues and organs that carry extra fluid from your cellstissues throughout the body If this lymph fluid is not able to flow in the body how it should there will be swelling which can lead to lymphedema It can be classified into stages 0 to 3 depending on the severity of the condition Stages 0 and 1 are reversible and through early diagnosis and treatment the recovery to the normal volume and normal skin status of arms can be possible On the other hand stage 2 or higher is irreversible and tissue fibrosis progresses and cannot return to normal skin therefore it is important to detect early and start treatment
This is an observational longitudinal study Potential participants will be recruited for follow-up after breast cancer surgery Only patients who fit the inclusion criteria will be considered for participation in the study and contacted by the healthcare provider Standard of care will be used to guide any treatment needed by participants while they are part of the study
This is an observational longitudinal study Potential participants will be recruited for follow-up after breast cancer surgery Only patients who fit the inclusion criteria will be considered for participation in the study and contacted by the healthcare provider Standard of care will be used to guide any treatment needed by participants while they are part of the study
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None